Human synthetic insulin may offer low-cost, effective treatment for certain patients with diabetes and financial constraints.
Alexandra M. Mapp, MPH
Advertisement
Articles by Alexandra M. Mapp, MPH
Advertisement
Latest Updated Articles
- Low-Cost Insulin for Socially At-Risk Patients: Evidence for Effectiveness
Published: June 11th 2021 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review
2
In Primary Care–Oncology Collaboration, the Baton Goes Both Ways
3
FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer
4
Supporting Pharmacy Residents in Completing Research Projects at UC Davis: Jeremiah J. Duby, PharmD, BCPS, BCCCP
5
